CD40LG and COVID-19: The seroconversion rate of IgG (90%) antibodies was higher than that of IgM (32%) antibodies after the onset of COVID-19, in contrast to the persistence of IgG antibodies, but also reveal IgG loss in around 50% of COVID-19 survivors 10 months after their recovery [7].